Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage

被引:43
作者
Bianco, NR [1 ]
Chaplin, LJ [1 ]
Montano, MM [1 ]
机构
[1] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA
关键词
breast cancer; oestrogen; oestrogen receptor beta; oxidative damage; phytoestrogens; quinone reductase;
D O I
10.1042/BJ20040959
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Quinone reductase (QR) is a phase II detoxification enzyme that plays an important role in detoxifying quinones and may help maintain the antioxidant function of the cell. We have previously observed that QR is up-regulated by anti-oestrogens, but not oestrogen, in breast cancer cells via ERbeta (oestrogen receptor beta) transactivation. Such QR induction appears to protect breast cells against oestrogen-induced oxidative DNA damage, most likely by reducing reactive oestrogen metabolites termed catecholestrogen-quinones back to the hydroxy-catecholestrogens which may be conjugated. We now report that the phytoestrogens biochanin A, genistein and resveratrol also up-regulate QR expression in breast cancer cells. We observe that regulation can occur at the transcriptional level, preferentially through ER,B transactivation at the electrophile response element of the QR gene promoter. By chromatin immunoprecipitation analysis, we show binding of ERalpha and ERbeta to the QR promoter, with increased ERbeta binding in the presence of resveratrol. Functional studies show that biochanin A and resveratrol, but not genistein, can significantly protect against oestrogen-induced oxidative DNA damage in breast cancer cells. Antisense technology was used to determine whether such protection was dependent on ERbeta or QR. Our results with resveratrol are consistent with our hypothesis that the protective ability of resveratrol is partially dependent on the presence of ERbeta and QR. In conclusion, we postulate that phytoestrogen-mediated induction of QR may represent an additional mechanism for breast cancer protection, although the effects may be specific for a given phytoestrogen.
引用
收藏
页码:279 / 287
页数:9
相关论文
共 49 条
  • [1] Estrogen receptor β-selective transcriptional activity and recruitment of coregulators by phytoestrogens
    An, JP
    Tzagarakis-Foster, C
    Scharschmidt, TC
    Lomri, N
    Leitman, DC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) : 17808 - 17814
  • [2] Barkhem Tomas, 2004, Am J Pharmacogenomics, V4, P19, DOI 10.2165/00129785-200404010-00003
  • [3] Begleiter A, 2004, METHOD ENZYMOL, V382, P320
  • [4] Critical role of oxidative stress in estrogen-induced carcinogenesis
    Bhat, HK
    Calaf, G
    Hei, TK
    Loya, T
    Vadgama, JV
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) : 3913 - 3918
  • [5] Functional implications of antiestrogen induction of quinone reductase: Inhibition of estrogen-induced deoxyribonucleic acid damage
    Bianco, NR
    Perry, G
    Smith, MA
    Templeton, DJ
    Montano, MM
    [J]. MOLECULAR ENDOCRINOLOGY, 2003, 17 (07) : 1344 - 1355
  • [6] Resveratrol acts as a mixed agonist/antagonist for estrogen receptors α and β
    Bowers, JL
    Tyulmenkov, VV
    Jernigan, SC
    Klinge, CM
    [J]. ENDOCRINOLOGY, 2000, 141 (10) : 3657 - 3667
  • [7] Castagnetta LAM, 2002, CLIN CANCER RES, V8, P3146
  • [8] Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial
    Cauley, JA
    Norton, L
    Lippman, ME
    Eckert, S
    Krueger, KA
    Purdie, DW
    Farrerons, J
    Karasik, A
    Mellstrom, D
    Ng, KW
    Stepan, JJ
    Powles, TJ
    Morrow, M
    Costa, A
    Silfen, SL
    Walls, EL
    Schmitt, H
    Muchmore, DB
    Jordan, VC
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2001, 65 (02) : 125 - 134
  • [9] Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201
  • [10] Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study
    Fisher, B
    Costantino, JP
    Wickerham, DL
    Redmond, CK
    Kavanah, M
    Cronin, WM
    Vogel, V
    Robidoux, A
    Dimitrov, N
    Atkins, J
    Daly, M
    Wieand, S
    Tan-Chiu, E
    Ford, L
    Wolmark, N
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) : 1371 - 1388